Posted by Michael Wonder on 26 Jun 2019
NICE to make changes to health technology evaluation
26 June 2019 - The Voluntary Scheme for Branded Medicines Pricing and Access, agreed by government and the ABPI in November 2018, commits NICE to scoping and initiating a review of its methods for both technology appraisals and highly specialised technologies, including a review of the process of guidance production for HST.
NICE is taking this opportunity to extend this exercise to include the methods and processes of the Medical Technologies Evaluation Programme and the Diagnostics Assessment Programme as well, aligning them where appropriate.
NICE has set up a steering group and working group with external membership to oversee the review. The steering group will have senior oversight of the methods and process review, while considering the changing national policy landscape and its impact.
